UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
     
     
FORM 8-K
     
     
 CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): March 10, 2015
     
     
TetraLogic Pharmaceuticals Corporation
(Exact name of Registrant as specified in its charter)
     
     
Delaware
001-36208
42-1604756
(State or Other Jurisdiction
of Incorporation or Organization)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
343 Phoenixville Pike
Malvern, PA 19355
(610) 889-9900
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
 
Not Applicable
(Former name or former address, if changed since last report)
     
     
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 5.02       Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On March 10, 2015, James N. Woody, M.D., Ph.D., a Director of TetraLogic Pharmaceuticals Corporation, a Delaware Corporation (the “Company”), resigned from the Board of Directors of the Company, effective March 13, 2015.
 
 
 
 
 
 
 
 
 
 
 
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: March 13, 2015
TetraLogic Pharmaceuticals Corporation
     
 
By:
/s/ Richard L. Sherman
 
   
Name: Richard L. Sherman
 
   
Title: Senior Vice President, Strategic
Transactions, General Counsel and Secretary